Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
CanBas
CanBas
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
CanBas
Stock Price
¥928
2024-10-29
Market Capitalization
¥16.8 B
2024-10-29
CanBas Summary
Company Summary
Overview
CanBas (キャンバス) is a drug discovery company engaged in the research and development of anti-cancer agents. Its drug candidates include a calmodulin modulator and a small molecule reversible inhibitor designed for the treatment of solid tumors.
Type
Public
Status
Active
Founded
2000
Website
http://www.canbas.co.jp/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
oncology
pharma
Homepage
facebook
twitter
Table of Contents
Financials
Competitors
CanBas Financials
Summary Financials
Net income (H1, 2026)
(¥569.0M)
Cash (H1, 2026)
¥2.2B
EBIT (H1, 2026)
(¥600.3M)
Competitors and Similar Companies
CureVac
Healthcare - Public
Tosk
Healthcare - Private
Polaris Pharmaceuticals
Healthcare - Private
EPICS Therapeutics
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top